Ho P C, Stephens I D, Triggs E J
Anaesth Intensive Care. 1981 May;9(2):113-8. doi: 10.1177/0310057X8100900202.
The placental transfer of alcuronium was studied in twelve patients undergoing elective or emergency caesarean section. Umbilical cord vein and maternal plasma was analysed for alcuronium at dose-delivery time intervals ranging from 5 to 10.5 minutes. The mean umbilical vein concentration of the relaxant was 0.41 +/- 0.18 (SD) microgram/ml, and the mean foetal/maternal concentration ratio was 0.26 +/- 0.11. A positive correlation between foetal and maternal concentrations of alcuronium was demonstrated. Although alcuronium appears to cross the placenta rapidly and in reasonably high concentration, no apparent adverse effects on the neonates was evident as judged by measurement of Apgar scores.
对12例行择期或急诊剖宫产的患者进行了阿库氯铵的胎盘转运研究。在给药后5至10.5分钟的时间间隔内,分析了脐静脉血和母体血浆中的阿库氯铵。松弛剂的平均脐静脉浓度为0.41±0.18(标准差)微克/毫升,平均胎儿/母体浓度比为0.26±0.11。阿库氯铵的胎儿和母体浓度之间存在正相关。尽管阿库氯铵似乎能迅速且以相当高的浓度穿过胎盘,但通过阿普加评分测量判断,对新生儿没有明显的不良影响。